Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2675 of 3284 entries
View as:

Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00878930 Org: User:
Start: 04/30/09 End: 12/31/10 Due: 12/31/11

A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS

Phase: N/A Priority: Normal
NCT ID: NCT01864005 Org: User:
Start: 05/31/13 End: 03/31/14 Due: 03/31/15

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Phase: N/A Priority: Normal
NCT ID: NCT03608358 Org: User:
Start: 02/27/19 End: 08/04/20 Due: 08/04/21

Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)

Phase: N/A Priority: Normal
NCT ID: NCT00305461 Org: User:
Start: 02/28/06 End: 02/29/08 Due: 02/28/09

The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users

Phase: N/A Priority: Normal
NCT ID: NCT01814943 Org: User:
Start: 11/30/12 End: 05/31/13 Due: 05/31/14

An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01325402 Org: User:
Start: 08/31/11 End: 11/30/12 Due: 11/30/13

A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00189514 Org: User:
Start: 09/30/05 End: 06/30/07 Due: 06/30/08

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01482221 Org: User:
Start: 12/16/11 End: 08/26/13 Due: 08/26/14

Economic Evaluation of Heart Failure Management in Colombian Clinics

Phase: N/A Priority: Normal
NCT ID: NCT01084564 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT04625972 Org: User:
Start: 12/02/20 End: 07/25/22 Due: 07/25/23

Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia

Phase: N/A Priority: Normal
NCT ID: NCT01700842 Org: User:
Start: 10/31/12 End: 12/31/12 Due: 12/31/13

Observational Prospective Study OPTIMA II - Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT02099565 Org: User:
Start: 05/31/14 End: 04/30/15 Due: 04/30/16

Saxagliptin Triple Oral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01128153 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

Benralizumab Pregnancy Exposure Study

Phase: N/A Priority: Normal
NCT ID: NCT03794999 Org: User:
Start: 03/20/19 End: 12/29/23 Due: 12/29/24

A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

Phase: N/A Priority: Normal
NCT ID: NCT06185660 Org: User:
Start: 02/09/24 End: 01/03/25 Due: 01/03/26

An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00135330 Org: User:
Start: 10/31/05 End: 07/31/08 Due: 07/31/09

A Blinded, Four-Way Crossover in Healthy Subjects to Assess EEG After Administration of Ketamine, Placebo and AZD6765

Phase: N/A Priority: Normal
NCT ID: NCT01130909 Org: User:
Start: 05/31/10 End: 01/31/11 Due: 01/31/12

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

Phase: N/A Priority: Normal
NCT ID: NCT01534936 Org: User:
Start: 02/29/12 End: 12/31/12 Due: 12/31/13

Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01095991 Org: User:
Start: 03/31/10 End: 05/31/10 Due: 05/31/11

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Phase: N/A Priority: Normal
NCT ID: NCT02582814 Org: User:
Start: 10/26/15 End: 06/15/17 Due: 06/15/18

A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT02482298 Org: User:
Start: 07/09/15 End: 11/16/16 Due: 11/16/17

Study to Assess Effect of HFO MDI Propellant on Mucociliary Clearance Vs. HFA MDI Propellant in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05755932 Org: User:
Start: 06/14/23 End: 07/22/24 Due: 07/22/25

ROMEO (Rosuvastatin in Metabolic syndrOme)

Phase: N/A Priority: Normal
NCT ID: NCT00395486 Org: User:
Start: 09/30/06 End: 06/30/08 Due: 06/30/09

This is a Study to Determine the Antidepressant Effects of AZD6765

Phase: N/A Priority: Normal
NCT ID: NCT00986479 Org: User:
Start: 12/31/09 End: 12/31/11 Due: 12/31/12

Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305

Phase: N/A Priority: Normal
NCT ID: NCT00915356 Org: User:
Start: 05/31/09 End: 12/31/09 Due: 12/31/10